CXCL8 and pancreatic neoplasm: Collectively, these findings indicate that CAFR regulates the NHEJ pathway via IL8 paracrine-dependent activation of UPK1A-AS1 expression to induce platinum resistance in pancreatic cancer (Fig. 8H).